Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 1/20 | 0.64 |
| ▸ | PKM | P14618 | 1/20 | 0.64 |
| ▸ | HPGD | P15428 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | HLCS | P50747 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | FASN | P49327 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2722732 | 0.98 | ALDH1A1 (0.62) | ALDH1A1KDM4EMEN1MAPTPKM | |
| SCHEMBL2580220 | 0.98 | ALDH1A1 (0.67) | ALDH1A1KDM4EMEN1MAPTPKM | |
| SCHEMBL6381412 | 0.91 | ALDH1A1 (0.60) | ALDH1A1KDM4EMEN1MAPTPKM | |
| SCHEMBL21496215 | 0.91 | ALDH1A1 (0.60) | ALDH1A1KDM4EMEN1MAPTPKM | |
| SCHEMBL9885892 | 0.91 | ALDH1A1 (0.60) | ALDH1A1KDM4EMEN1MAPTPKM | |
| SCHEMBL472596 | 0.91 | ALDH1A1 (0.60) | ALDH1A1KDM4EMEN1MAPTPKM | |
| SCHEMBL9063018 | 0.91 | ALDH1A1 (0.76) | ALDH1A1KDM4EMEN1MAPTPKM | |
| SCHEMBL3911611 | 0.89 | ALDH1A1 (0.62) | ALDH1A1KDM4EMEN1MAPTPKM | |
| SCHEMBL19528506 | 0.88 | ALDH1A1 (0.56) | ALDH1A1KDM4EMEN1MAPTPKM | |
| SCHEMBL9240496 | 0.85 | ALDH1A1 (0.53) | ALDH1A1KDM4EMEN1MAPTPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103249416-B | Sustained-release preparation for injection | 大日本住友制药株式会社 | 2019-06-04 | — | — | CN | claimed |
| CN-107625728-A | Injectable sustained release preparation | 大日本住友制药株式会社 | 2018-01-26 | — | — | CN | claimed |
| CN-107595771-A | Injectable sustained release preparation | 大日本住友制药株式会社 | 2018-01-19 | — | — | CN | claimed |
| EP-2629775-A1 | SUSTAINED-RELEASE FORMULATION FOR INJECTION | Dainippon Sumitomo Pharma Co., Ltd. (JP) | 2013-08-28 | — | — | EP | claimed |
| CN-103249416-A | Sustained-release preparation for injection | DAINIPPON SUMITOMO PHARMA CO | 2013-08-14 | — | — | CN | claimed |
| WO-2012053654-A1 | SUSTAINED-RELEASE FORMULATION FOR INJECTION | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2012-04-26 | — | — | WO | claimed |
| CN-103249416-B | Sustained-release preparation for injection | 大日本住友制药株式会社 | 2019-06-04 | — | — | CN | disclosed |
| CN-103249416-B | Sustained-release preparation for injection | 大日本住友制药株式会社 | 2019-06-04 | — | — | CN | disclosed |
| CN-107625728-A | Injectable sustained release preparation | 大日本住友制药株式会社 | 2018-01-26 | — | — | CN | disclosed |
| CN-107625728-A | Injectable sustained release preparation | 大日本住友制药株式会社 | 2018-01-26 | — | — | CN | disclosed |
| CN-107595771-A | Injectable sustained release preparation | 大日本住友制药株式会社 | 2018-01-19 | — | — | CN | disclosed |
| CN-107595771-A | Injectable sustained release preparation | 大日本住友制药株式会社 | 2018-01-19 | — | — | CN | disclosed |
| EP-2629775-A1 | SUSTAINED-RELEASE FORMULATION FOR INJECTION | Dainippon Sumitomo Pharma Co., Ltd. (JP) | 2013-08-28 | — | — | EP | disclosed |
| CN-103249416-A | Sustained-release preparation for injection | DAINIPPON SUMITOMO PHARMA CO | 2013-08-14 | — | — | CN | disclosed |
| EP-2601187-A1 | DEUTERATED TANDOSPIRONE DERIVATIVES AS 5-HT1A RECEPTOR AGONISTS | Conrig Pharma ApS (DK) | 2013-06-12 | — | — | EP | disclosed |
| WO-2012053654-A1 | SUSTAINED-RELEASE FORMULATION FOR INJECTION | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2012-04-26 | — | — | WO | disclosed |
| WO-2012016569-A1 | DEUTERATED TANDOSPIRONE DERIVATIVES AS 5-HT1A RECEPTOR AGONISTS | CONRIG PHARMA APS (DK) | 2012-02-09 | — | — | WO | disclosed |